BROADCASTS.com

b'Cilv\\u0113ku skaits pasaul\\u0113 pieaug, pieaug ar\\u012b medikamentu pat\\u0113ri\\u0146\\u0161. L\\u012bdz\\u012bgi k\\u0101 ar jebkuru preci un produktu \\u0161obr\\u012bd, ar\\u012b z\\u0101\\u013cu atliekvielas non\\u0101k vid\\u0113. Eso\\u0161\\u0101s tehnolo\\u0123ijas nesp\\u0113j piln\\u012bb\\u0101 att\\u012br\\u012bt vidi no \\u0161\\u0101da pies\\u0101r\\u0146ojuma, t\\u0101p\\u0113c visas cer\\u012bbas tiek liktas uz zin\\u0101tniekiem, kas n\\u0101ks klaj\\u0101 ar jaun\\u0101m metod\\u0113m z\\u0101\\u013cvielu pies\\u0101r\\u0146ojuma mazin\\u0101\\u0161an\\u0101.\\n\\nP\\u0113tniece Brigita Da\\u013cecka aizst\\u0101v\\u0113jusi promocijas darbu R\\u012bgas Tehniskaj\\u0101 universit\\u0101t\\u0113 un Zviedrijas Karaliskaj\\u0101 tehnolo\\u0123iju instit\\u016bta par mikroskopisku s\\u0113\\u0146u pielietojumu farm\\u0101cijas vielu pies\\u0101r\\u0146ojuma att\\u012br\\u012b\\u0161an\\u0101. K\\u0101 veidojas \\u0161\\u0101ds pies\\u0101r\\u0146ojums? K\\u0101ds ir ce\\u013c\\u0161 no medikamentiem m\\u016bsu m\\u0101jas aptieci\\u0146\\u0101s l\\u012bdz notek\\u016bde\\u0146iem un k\\u0101 att\\u012br\\u012bt vidi no farm\\u0101cijas vielu pies\\u0101r\\u0146ojuma \\u013cauj da\\u017e\\u0101das tehnolo\\u0123ijas, raid\\u012bjum\\u0101 Zin\\u0101mais nezin\\u0101maj\\u0101 skaidro R\\u012bgas Tehnisk\\u0101s universit\\u0101tes un Zviedrijas Karalisk\\u0101 tehnolo\\u0123iju instit\\u016bta doktore Brigita Da\\u013cecka un zin\\u0101tnisk\\u0101 instit\\u016bta "BIOR" p\\u0113tnieks \\u0137\\u012bmijas doktors Ingus P\\u0113rkons.\\n\\nBrigita Da\\u013cecka nor\\u0101da, ka l\\u012bdz \\u0161im da\\u017e\\u0101das metodes apskat\\u012btas, k\\u0101 notek\\u016bde\\u0146us att\\u012br\\u012bt no farmaceitiski akt\\u012bv\\u0101m viel\\u0101m, bet t\\u0101 k\\u0101 sird\\u012b ir mikrobiologs, vi\\u0146u interes\\u0113 biolo\\u0123isk\\u0101 att\\u012br\\u012b\\u0161ana.\\n\\n"T\\u0101p\\u0113c apl\\u016bkoju mikroskopisk\\u0101s s\\u0113nes, jo t\\u0101s sp\\u0113j augot veidot lielu biomasu, ko var izmantot notek\\u016bde\\u0146u att\\u012br\\u012b\\u0161an\\u0101 no farmaceitiski akt\\u012bvaj\\u0101m viel\\u0101m. Biomasa var absorb\\u0113t akt\\u012bv\\u0101s vielas. Otrs - s\\u0113n\\u0113m piem\\u012bt enz\\u012bmi, kas ir akt\\u012bvas vielas, ko izdala vielmai\\u0146as proces\\u0101, un tie var sadal\\u012bt farmaceitiski akt\\u012bv\\u0101s vielas un att\\u012br\\u012bt notek\\u016bde\\u0146us," skaidro Brigita Da\\u013cecka.\\n\\nIzstr\\u0101d\\u0101jot darbu, vi\\u0146a mekl\\u0113ja att\\u012br\\u012b\\u0161anai piem\\u0113rot\\u0101k\\u0101s s\\u0113nes. S\\u0101ka ar k\\u0101d\\u0101m 10 s\\u0113n\\u0113m, izraudz\\u012bj\\u0101s visefekt\\u012bv\\u0101ko, bet tas neizsl\\u0113dz, ka v\\u0113l k\\u0101das s\\u0113nes nevar\\u0113tu izmantot. T\\u0101pat ar\\u012b Brigita Da\\u013cecka p\\u0113t\\u012bja, k\\u0101das mikroskopisk\\u0101s s\\u0113nes jau ir notek\\u016bde\\u0146os pa\\u0161as par sevi un vai t\\u0101s ar\\u012b izmantot farmaceitisk\\u0101 pies\\u0101r\\u0146ojuma mazin\\u0101\\u0161anai.\\n\\nBIOR jau veicis p\\u0113t\\u012bjumus par farmaceitisko vielu kl\\u0101tb\\u016btni jau att\\u012br\\u012btos notek\\u016bde\\u0146os un ar to iepaz\\u012bstin\\u0101ja ar\\u012b raid\\u012bjum\\u0101 Zin\\u0101mais nezin\\u0101maj\\u0101.\\n\\nBrigita Da\\u013cecka atz\\u012bst, ka s\\u0101kum\\u0101 dom\\u0101ja, ka vi\\u0146as izstr\\u0101d\\u0101t\\u0101 metode var\\u0113tu b\\u016bt notek\\u016bde\\u0146u pirmsatt\\u012br\\u012b\\u0161ana, tagad tom\\u0113r sliecas dom\\u0101t, ka t\\u0101 var\\u0113tu b\\u016bt p\\u0113catt\\u012br\\u012b\\u0161ana, kad jau notek\\u016bde\\u0146i ir izg\\u0101ju\\u0161i cauri visiem klasiskajiem att\\u012br\\u012b\\u0161ana meh\\u0101nismiem.\\n\\n"Pievieno k\\u0101 ekstra soli metodi, kas fokus\\u0113jas uz b\\u012bstamo vielu att\\u012br\\u012b\\u0161anu," bilst Brigita Da\\u013cecka. "Metodei v\\u0113l ir daudz izaicin\\u0101jumu. Pirm\\u0101 - process, k\\u0101 tas notiek, cik daudz s\\u0113nes biomasas nepiecie\\u0161ama, lai efekt\\u012bvi att\\u012br\\u012btu no pies\\u0101r\\u0146ojuma un k\\u0101 \\u0161\\u012b biomasa iedarbojas ar dabiskiem mikroorganiskiem, kas jau ir \\u016bden\\u012b.\\n\\n\\nTas ir liels izaicin\\u0101jums, jo s\\u0113nes ir cimperl\\u012bgas un nem\\u012bl sev apk\\u0101rt citus mikroorganismus. J\\u0101risina jaut\\u0101jums, k\\u0101 atrasts balansu, kur\\u0101 mirkl\\u012b s\\u0113ne var efekt\\u012bvi att\\u012br\\u012bt un ar\\u012b dz\\u012bvot \\u016bden\\u012b."\\n\\n\\nIngus P\\u0113rkons atz\\u012bst, ka j\\u0101v\\u0113rt\\u0113 metodes rentabilit\\u0101te. S\\u0113\\u0146u kult\\u016bru ievie\\u0161ana k\\u0101 papildus att\\u012br\\u012b\\u0161anas stadija ir \\u013coti perspekt\\u012bva.\\n\\nIngus P\\u0113rkons nor\\u0101da, lai ar\\u012b liel\\u0101ko apjomu farmaceitisk\\u0101 pies\\u0101r\\u0146ojuma notek\\u016bde\\u0146os rada medikamentu pat\\u0113r\\u0113t\\u0101ji, t\\u016bl\\u012bt\\u0113jas sekas var rad\\u012bt ra\\u017eot\\u0101ji.\\xa0Pilottehnolo\\u0123ijas j\\u0101izmanto, lai uzlabotu notek\\u016bde\\u0146u att\\u012br\\u012b\\u0161anas iesp\\u0113jas z\\u0101\\u013cu ra\\u017eotn\\u0113s, tad v\\u0113rts piev\\u0113rsties pils\\u0113tu notek\\u016bde\\u0146u att\\u012br\\u012b\\u0161anas sist\\u0113mai.\\n\\nNaftas pies\\u0101r\\u0146ojums un t\\u0101 likvid\\u0113\\u0161ana\\n\\nNaftas produktu pies\\u0101r\\u0146ojums \\u012asl\\u012bc\\u0113 un Buti\\u0146\\u0123es naftas termin\\u0101l\\u012b ir nesen\\u0101kie pa\\u0161m\\u0101ju atg\\u0101din\\u0101jumi, kuros naftas produkti non\\u0101ku\\u0161i apk\\u0101rt\\u0113j\\u0101 vid\\u0113. Ar k\\u0101d\\u0101m metod\\u0113m un tehnolo\\u0123ij\\u0101m likvid\\u0113 \\u0161o pies\\u0101r\\u0146ojumu un cik ilgi tas saglab\\u0101jas vid\\u0113 un k\\u0101da ir naftas produktu ietekme uz vidi, skaidro Latvijas hidroekolo\\u0123ijas instit\\u016bta p\\u0113tniece Rita Poik\\u0101ne un Valsts vides dienesta speci\\u0101liste Evita Beitlere.'